Recombinant activated protein C treatment improves tissue perfusion and oxygenation in septic patients measured by near-infrared spectroscopy

Critical Care

Volumn 13, Issue , 2009, Pages

  Donati, Abele ^a   Romanelli, Michela ^a   Botticelli, Laura ^a   Valentini, Agnese ^a   Gabbanelli, Vincenzo ^a   Nataloni, Simonetta ^a   Principi, Tiziana ^a   Pelaia, Paolo ^a   Bezemer, Rick ^b   Ince, Can ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Oxygen Consumption Rate; Septic Patient; Sequential Organ Failure Assessment; Sequential Organ Failure Assessment Score; Severe Sepsis

Indexed keywords

PROTEIN C; RECOMBINANT PROTEIN;

ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; OXYGEN CONSUMPTION; PHYSIOLOGY; PROSPECTIVE STUDY; SEPTIC SHOCK;

FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; PROTEIN C; RECOMBINANT PROTEINS; SHOCK, SEPTIC; SPECTROSCOPY, NEAR-INFRARED;

MLCS; MLOWN;

EID: 77952540351     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8010     Document Type: Article

References (25)

1. Ince C: The microcirculation is the motor of sepsis. Crit Care 2005,9(Suppl 4):13-19. 10.1186/cc3753 DOI: 10.1186/cc3753
2. De Backer D, Creteur J, Preiser J, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care 2002, 166: 98-104. 10.1164/rccm.200109-016OC DOI: 10.1164/rccm.200109-016OC
3. Astiz ME, DeGent GE, Lin RY, Rackow EC: Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med 1995, 23: 265-271. 10.1097/00003246-199502000-00011 DOI: 10.1097/00003246-199502000-00011
4. Trzeciak S, McCoy JV, Dellinger RP, Arnold RC, Rizzuto M, Abate NL, Shapiro NI, Parrillo JE, Hollenberg SM, Microcirculatory Alterations in Resuscitation and Shock (MARS) investigators: Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008, 34: 2210-2217. 10.1007/s00134-008-1193-6 DOI: 10.1007/s00134-008-1193-6
5. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001 DOI: 10.1056/NEJM200103083441001
6. Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, Wong K, Sundin DP, Turlo MA, Janes J: Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med 2005, 33: 2266-2277. 10.1097/01.CCM.0000181729.46010.83 DOI: 10.1097/01.CCM.0000181729.46010.83
7. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banocloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM: Surviving Sepsis Campaign Management Guidelines Committee: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32: 858-873. 10.1097/01.CCM.0000117317.18092.E4 DOI: 10.1097/01.CCM.0000117317.18092.E4
8. Boushel R, Langberg H, Olesen J, Gonzales-Alonzo J, Bulow J, Kjaer M: Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports 2001, 11: 213-222. 10.1034/j.1600-0838.2001.110404.x DOI: 10.1034/j.1600-0838.2001.110404.x
9. Ward KR, Ivatury RR, Barbee RW, Terner J, Pittman R, Filho IP, Spiess B: Near infrared spectroscopy for evaluation of the trauma patient: a technology review. Resuscitation 2006, 68: 27-44. 10.1016/j.resuscitation.2005.06.022 DOI: 10.1016/j.resuscitation.2005.06.022
10. De Blasi RA, Palmisani S, Alampi D, Mercieri M, Romano R, Collini S, Pinto G: Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock. Intensive Care Med 2005, 31: 1661-1668. 10.1007/s00134-005-2822-y DOI: 10.1007/s00134-005-2822-y
11. Knotzer H, Pajk W, Dunser MW, Majer S, Mayr AJ, Ritsch N, Friesenecker B, Hasibeder WR: Regional microvascular reactivity in patients with different degree of multiple organ dysfynction syndrome. Anesth Analg 2006, 102: 1187-1193. 10.1213/01.ane.0000198587.10553.c1 DOI: 10.1213/01.ane.0000198587.10553.c1
12. 2 in septic patients. Intensive Care Med 2007, 33: 1549-1556. 10.1007/s00134-007-0739-3 DOI: 10.1007/s00134-007-0739-3
13. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29: 530-538. DOI: 10.1007/s00134-003-1662-x
14. Jhanji S, Stirling S, Patel N, Hinds CJ, Pearse RM: The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 2009, 37: 1961-1966. 10.1097/CCM.0b013e3181a00a1c DOI: 10.1097/CCM.0b013e3181a00a1c
15. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF: Nitroglycerin in septic shock after intravascular volume resuscitation. The Lancet 2002, 360: 1395-1396. 10.1016/S0140-6736(02)11393-6 DOI: 10.1016/S0140-6736(02)11393-6
16. Macias WL, Yan SB, Williams MD, Um SL, Sandusky GE, Ballard DW, Planquois JM: New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). Crit Care 2005,9(Suppl 4):38-45. 10.1186/cc3747 DOI: 10.1186/cc3747
17. Yamaji K, Wang Y, Liu Y, Abeyama K, Hashiguchi T, Uchimura T, Krishna Biswas K, Iwamoto H, Maruyama I: Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. Thromb Res 2005, 115: 319-325. 10.1016/j.thromres.2004.09.011 DOI: 10.1016/j.thromres.2004.09.011
18. Gierer P, Hoffmann JN, Mahr F, Menger MD, Mittlmeier T, Gradl G, Vollmar B: Activated protein C reduces tissue hypoxia, inflammation, and apoptosis in traumatized skeletal muscle during endotoxiemia. Crit Care Med 2007, 35: 1966-1971. 10.1097/01.CCM.0000275270.14835.2A DOI: 10.1097/01.CCM.0000275270.14835.2A
19. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Fertmann J, Schildberg FW, Menger MD: Microhemodynamic and cellularmechanisms of activated protein action during endotoxemia. Crit Care Med 2004, 32: 1011-1017. 10.1097/01.CCM.0000120058.88975.42 DOI: 10.1097/01.CCM.0000120058.88975.42
20. Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A, Okabe K: Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 2001, 104: 1171-1175. 10.1161/hc3501.093799 DOI: 10.1161/hc3501.093799
21. Marechal X, Favory R, Joulin O, Montaigne D, Hassoun S, Decoster B, Zerimech F, Neviere R: Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008, 29: 572-576. 10.1097/SHK.0b013e318157e926
22. De Backer D, Verdant C, Chierego M, Koch M, Gullo A, Vincent JL: Effects of drotrecogin alfa activated protein C on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006, 34: 1-7.
23. Doerschug KC, Delsing AS, Schmidt GA, Haynes WG: Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 2007, 293: 1065-1071. 10.1152/ajpheart.01237.2006 DOI: 10.1152/ajpheart.01237.2006
24. Skarda DE, Mulier KE, Myers DE, Taylor JH, Beilman GJ: Dynamic near-infrared spectroscopy measurements in patients with severe sepsis. Shock 2007, 27: 345-353. 10.1097/01.shk.0000239779.25775.e4 DOI: 10.1097/01.shk.0000239779.25775.e4
25. Pareznik R, Knezevic R, Voga G, Podbregar M: Changes in muscle tissue oxygenation during stagnant ischemia in septic patients. Intensive Care Med 2006, 32: 87-92. 10.1007/s00134-005-2841-8 DOI: 10.1007/s00134-005-2841-8